TG THERAPEUTICS ANNOUNCES PHASE 1 DATA EVALUATING AZER-CEL IN PROGRESSIVE MULTIPLE SCLEROSIS IN A LATE-BREAKING ORAL PRESENTATION AT MSTORONTO2026

Reuters · 3d ago

Please log in to view news